In a retrospective study in the UK (29), 77% (20/26) of anti-LGI1 encephalitis patients experienced FBDS prior to the development of limbic encephalitis and found that early immunotherapy for FBDS might prevent progression to cognitive impairment. This evidence concerns the gene LGI1 and viral encephalitis.